(Yicai) March 4 -- Shares of Asieris Pharmaceuticals soared by their daily trading limit after China granted the drugmaker marketing approval for Cevira, the world’s first non-surgical, non-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results